Found: 36
Select item for more details and to access through your institution.
Lung Cancer in US Women: A Contemporary Epidemic.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 291, n. 14, p. 1763, doi. 10.1001/jama.291.14.1763
- By:
- Publication type:
- Article
Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.576314
- By:
- Publication type:
- Article
Leptomeningeal metastases: the future is now.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 156, n. 3, p. 443, doi. 10.1007/s11060-021-03924-2
- By:
- Publication type:
- Article
Current and Emerging Treatment Options for Patients with Metastatic EGFR-Mutated Non-small Cell Lung Cancer After Progression on Osimertinib and Platinum-Based Chemotherapy: A Podcast Discussion.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 12, p. 5579, doi. 10.1007/s12325-023-02680-1
- By:
- Publication type:
- Article
Biomarker Testing for Breast, Lung, and Gastroesophageal Cancers at NCI Designated Cancer Centers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 10, p. 1, doi. 10.1093/jnci/dju256
- By:
- Publication type:
- Article
Biomarker Testing for Breast, Lung, and Gastroesophageal Cancers at NCI Designated Cancer Centers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 10, p. 1, doi. 10.1093/jnci/dju256
- By:
- Publication type:
- Article
Phase I/II Trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced Non–Small Cell Lung Cancer: Hoosier Cancer Research Network LUN13-175.
- Published in:
- Oncologist, 2024, v. 29, n. 1, p. 47, doi. 10.1093/oncolo/oyad180
- By:
- Publication type:
- Article
Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Identifying Resistance Mechanisms to Osimertinib via Blood Biopsy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pemetrexed Continuation Maintenance Phase 3 Trials in Nonsquamous, Non-Small-Cell Lung Cancer: Focus on 2-Year Overall Survival and Continuum of Care.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Top advances in lung cancer, 2021.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Correlation of EGFR Mutation Status With Predominant Histologic Subtype of Adenocarcinoma According to the New Lung Adenocarcinoma Classification of the International Association for the Study of Lung Cancer/ American Thoracic Society/European...
- Published in:
- Archives of Pathology & Laboratory Medicine, 2014, v. 138, n. 10, p. 1353, doi. 10.5858/arpa.2013-0376-OA
- By:
- Publication type:
- Article
Molecular Profiling in Non-Small Cell Lung Cancer: A Step Toward Personalized Medicine.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Molecular Profiling in Non-Small Cell Lung Cancer: A Step Toward Personalized Medicine.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2013, v. 137, n. 4, p. 481, doi. 10.5858/arpa.2012-0287-RA
- By:
- Publication type:
- Article
Maintenance treatment after induction therapy in non-small cell lung cancer: latest evidence and clinical implications.
- Published in:
- Therapeutic Advances in Medical Oncology, 2014, v. 6, n. 1, p. 4, doi. 10.1177/1758834013510589
- By:
- Publication type:
- Article
Is immune checkpoint inhibition part of standard therapy for stage III non‐small cell lung cancer?
- Published in:
- Cancer (0008543X), 2018, v. 124, n. 14, p. 2878, doi. 10.1002/cncr.31557
- By:
- Publication type:
- Article
Is immune checkpoint inhibition part of standard therapy for stage III non-small cell lung cancer?
- Published in:
- 2018
- By:
- Publication type:
- journal article
A randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive-stage small cell lung cancer: Hoosier Cancer Research Network LUN06-113.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 24, p. 3853, doi. 10.1002/cncr.28956
- By:
- Publication type:
- Article
Evaluating the Supportive Care Costs of Severe Radiochemotherapy-Induced Mucositis and Pharyngitis.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 6, p. 1446, doi. 10.1002/cncr.23714
- By:
- Publication type:
- Article
Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdac183
- By:
- Publication type:
- Article
Reversible Nyctalopia and Retinopathy in a Patient With Metastatic Cancer Treated With Anti-Heat Shock Protein 90 Therapy.
- Published in:
- JAMA Ophthalmology, 2014, v. 132, n. 7, p. 899, doi. 10.1001/jamaophthalmol.2014.409
- By:
- Publication type:
- Article
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-99524-1
- By:
- Publication type:
- Article
Emerging Concepts in the Pathology and Molecular Biology of Advanced Non--Small Cell Lung Cancer.
- Published in:
- American Journal of Clinical Pathology, 2011, v. 136, n. 2, p. 228, doi. 10.1309/AJCPO66OIRULFNLZ
- By:
- Publication type:
- Article
Regulation of VEGFR2 and AKT Signaling by Musashi-2 in Lung Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2529, doi. 10.3390/cancers15092529
- By:
- Publication type:
- Article
The Prognostic and Therapeutic Potential of DNA Damage Repair Pathway Alterations and Homologous Recombination Deficiency in Lung Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5305, doi. 10.3390/cancers14215305
- By:
- Publication type:
- Article
Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3164, doi. 10.3390/cancers13133164
- By:
- Publication type:
- Article
Bevacizumab in Advanced NSCLC: Chemotherapy Partners and Duration of Use.
- Published in:
- Current Treatment Options in Oncology, 2013, v. 14, n. 4, p. 595, doi. 10.1007/s11864-013-0255-3
- By:
- Publication type:
- Article
Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non-Small-Cell Lung Cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed- Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non-Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 3, p. 200, doi. 10.1016/j.cllc.2014.11.004
- By:
- Publication type:
- Article
Importance and relevance of pulmonary symptoms among patients receiving second- and third-line treatment for advanced non-small-cell lung cancer: support for the content validity of the 4-item pulmonary symptom index.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Importance and Relevance of Pulmonary Symptoms Among Patients Receiving Second and Third-Line Treatment for Advanced Non-Small-Cell Lung Cancer: Support for the Content Validity of the 4-Item Pulmonary Symptom Index.
- Published in:
- Clinical Lung Cancer, 2013, v. 14, n. 3, p. 245, doi. 10.1016/j.cllc.2012.07.001
- By:
- Publication type:
- Article
Treatment Rationale and Study Design for the PointBreak Study: A Randomized, Open-label Phase III Study of Pemetrexed/Carboplatin/Bevacizumab Followed by Maintenance Pemetrexed/Bevacizumab Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer
- Published in:
- Clinical Lung Cancer, 2009, v. 10, n. 4, p. 252, doi. 10.3816/CLC.2009.n.035
- By:
- Publication type:
- Article
Early Stage Lung Cancer Detection in Systemic Sclerosis Does Not Portend Survival Benefit: A Cross Sectional Study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0117829
- By:
- Publication type:
- Article
Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 2, p. 664, doi. 10.1111/cts.12928
- By:
- Publication type:
- Article